Reducing Fraudulent and Imitation Drugs Act of 2007

S.1082 Prescription Drug User Fee Amendments of 2007 H.R.2716 Reducing Fraudulant and Imitative Drugs Act of 2007 S.242/S.251 Pharmaceutical Marketing Access Act of 2007 The Prescription Drug Marketing Act and various other bills and amendments relating to anti-counterfeiting/pedigree issues. H.R.5839 Safeguarding America's Pharmaceuticals Act of 2008 Various bill and amendments relating to drug importation The Food and Drug Amendments Act of 2007 H.R.3610 Food and Drug Import Safety Act of 2007 Various bills and amendments relating to drug safety and inspection of foreign drug manufacturing facilities.

Client expense: $155,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

HR 2716 and HR 4299 - To Extend the Terrorism Risk Insurance Act. S 618 and HR 1081 - To End the Insurance Industry's Antitrust Exemption under the McCarran-Ferguson Act. S. 40 and HR 3200 - To Establish an Optional Federal Charter for Insurance Companies. Supported bill to reduce regulatory/filing burden on surplus lines insurers. HR 5840 in support of an Office of Insurance Information. H.R. 1424 Emergency Economic Stabilization Act of 2008- Provisions dealing with Federal Deposit Insurance Corporation

Client expense: Not reported · Firm income: $30,000

Government targets: Federal Reserve System, HOUSE OF REPRESENTATIVES, SENATE

S.1082 Prescription Drug User Fee Amendments of 2007 H.R.2716 Reducing Fraudulant and Imitative Drugs Act of 2007 S.242/S.251 Pharmaceuctical Marketing Access Act of 2007 The Prescription Drug Marketing Act and various other bills and amendments relating to anit-counterfeiting/pedigree issues. H.R.5839 Safeguarding America's Pharmcaeuticals Act of 2008 Various bills and amendments relating to drug importation The Food and Drug Amendments Act of 2007 H.R.3610 Food and Drug Import Safety Act of 2007 Various bills and amendments relating to drug safety and inspection of foreign drug manufacturing facilities.

Client expense: $230,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

HR 2716 and HR 4299 - To Extend the Terrorism Risk Insurance Act. S 618 and HR 1081 - To End the Insurance Industry's Antitrust Exemption under the McCarran-Ferguson Act. S. 40 and HR 3200 - To Establish an Optional Federal Charter for Insurance Companies. Supported bill to reduce regulatory/filing burden on surplus lines insurers. HR 5840, in support of an Office of Insurance Information.

Client expense: $180,000 · Firm income: Not reported

Government targets: Federal Housing Finance Agency (FHFA), Federal Reserve System, HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Natl Credit Union Administration (NCUA), SENATE, Treasury, Dept of

HR 2716 and HR 4299 - To Extend the Terrorism Risk Insurance Act. S 618 and HR 1081 - To End the Insurance Industry's Antitrust Exemption under the McCarran-Ferguson Act. S. 40 and HR 3200 - To Establish an Optional Federal Charter for Insurance Companies. Supported bill to reduce regulatory/filing burden on surplus lines insurers. HR 5840 in support of an Office of Insurance Information.

Client expense: Not reported · Firm income: $20,000

H.R. 1902 Protecting Consumers Access to Generic Drugs Act of 2007 S. 316 Preserve Access to Affordable Generics Act S. 1082 Prescription Drug User Fee Amendments of 2007 H.R. 2716 Reducing Fraudulant and Imitative Drugs Act of 2007 S. 251 Pharmaceutical Marketing Access Act of 2007 The Prescription Drug Marketing Act and various other bills and amendments relating to anti-counterfeiting /pedigree issues. Various bills and amendments relating to drug importation. The Food and Drug Administration Amendments Act of 2007 S. 1951 Fair Medicaid Drug Payment Act H.R. 3140 Saving our Community Pharmacies Act H.R. 3193 Access to Community Pharmacy Preservation Act Various bills and amendments relating to drug safety and inspection of foreign drug manufacturing facilities.

Client expense: $295,390 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

See addendum. 1.S.242/H.R.380, the Pharmaceutical Market Access and Drug Safety Act of 2007, as related to provisions governing the importation of prescription drugs. 2.S.251, the Pharmaceutical Market Access Act of 2007, all provisions governing the importation of prescription drugs. 3.S. 484, the Enhancing Drug Safety and Innovation Act of 2007, all provisions related to the safety of prescription medicines. 4.S. 604, the Military Health Care Protection Act, as related to provider participation in the Department of Defense TRICARE program. 5.S. 980, Online Pharmacy Consumer Protection Act of 2007, as related to the regulation of online pharmacies. 6.S. 1200, Indian Health Care Improvement Act Amendments of 2007, all provisions related to reducing fraud and abuse in the Medicare program. 7.S. 1276/H.R.2747, the Methamphetamine Production Prevention Act of 2007, as related to the distribution of legal substances used in the production of methamphetamine. 8.S. 1693, the Wired for Health Care Quality Act of 2007, as related to improving health information technology. 9.S. 1695, the Biologics Price Competition and Innovation Act of 2007, as related to the approval of generic biopharmaceuticals. 10.S. 1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007 as related to provider participation in the Medicare program. 11.S.1915, Electronic Prescription Drug Act of 2007, as related to the regulation of electronic prescribing of pharmaceuticals 12.S.1951/H.R.3700, Fair Medicaid Drug Payment Act of 2007, as related to Medicaid provider reimbursement. 13.S.1954, Pharmacy Access Improvement (PhAIm) Act of 2007, as related to access standards to pharmacies. 14.S.2013/H.R.3090, Patient and Pharmacy Protection Act of 2007, as related to prescription requirements in the Medicaid program. 15.S.2071, Combat Methamphetamine Enhancement Act of 2007, as related to the distribution of legal substances used in the production of methamphetamine. 16.S.2274, Dextromethorphan Abuse Reduction Act of 2007, as related to steps to prevent the abuse of dextromethorphan. 17.S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to the regulation of electronic prescribing of pharmaceuticals. 18.H.R.976, Small Business Tax Relief Act of 2007, all provisions associated with work-related tax credits. 19.H.R. 970, the Dextromethorphan Distribution Act of 2007, as related to steps to prevent the abuse of dextromethorphan. 20.H.R. 971/S.855, the Community Pharmacy Fairness Act of 2007, as related to provider negotiations in the Medicare program. 21.H.R.1038/S.623, Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. 22.H.R. 1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007, as related to provider reimbursement in the Medicare program 23.H.R.1585/S.1548, National Defense Authorization Act for Fiscal Year 2008, as related to retail pharmacy participation in the Department of Defense TRICARE program. 24.H.R.1845, the Medicare Durable Medical Equipment Access Act of 2007, as related to provider inclusion in the Medicare Part B program. 25.H.R.1902, the Protecting Consumer Access to Generic Drugs Act of 2007, as related to the availability of generic pharmaceuticals. 26.H.R.2716, the Reducing Fraudulent and Imitation Drugs Act of 2007, as related to the safety of prescription drugs. 27.H.R. 2900, the Food and Drug Administration Amendments of 2007, all provisions related to prescription drug information and safety. 28.H.R.3109, the Dental Health Promotion Act of 2007, all provisions related to payment for health services. 29.H.R.3140, Saving Our Community Pharmacies Act of 2007, as related to Medicaid provider reimbursement. 30.H.R.3162, Children's Health and Medicare Protection Act of 2007, provisions related to health insurance in the Medicare program. 31.H.R.3193, Access to Community Pharmacy Preservation Act of 2007, as related to Medicaid provider reimbursement. 32.H.R.3580, Food and Drug Administration Amendments Act of 2007, all provisions related to prescription drug information and safety. 33.H.R.3610, Food and Drug Import Safety Act of 2007, provisions related to the safety of prescription drugs. 34.H.R.5268/S.2620, Temporary Increase of Medicaid FMAP, all provisions related to payments in the Medicaid program. 35.H.R.5480/S.2662, Medicare Funding Warning Response Act of 2008, all provisions related to provider access and payments in the Medicare program. 36.H.R.5491, Emilys Act, as related to the certification of pharmacy technicians. 37.H.R.5546, Credit Card Fair Fee Act of 2008, as related to fees associated with credit card purchase. 38.H.R.5613, Protecting the Medicaid Safety Net Act of 2008, all provisions related to provider participation in the Medicaid program. 39.H.R.5629, Pathway for Biosimilars Act, as related to the availability of generic pharmaceuticals. 40.H.Con.Res.312/S.Con.Res.70, Concurrent Resolution on the Budget for Fiscal Year 2009, all provisions related to healthcare providers and prescription drugs.

HR 2716 and HR 4299 - To Extend the Terrorism Risk Insurance Act. S 618 and HR 1081 - To End the Insurance Industry's Antitrust Exemption under the McCarran-Ferguson Act. S. 40 and HR 3200 - To Establish an Optional Federal Charter for Insurance Companies. Supported bill to reduce regulatory/filing burden on surplus lines insurers.

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of

H.R.1902 Protecting Consumers Access to Generic Drugs Act of 2007 S.316 Preserve Access to Affordable Generics Act H.R.2900 Food and Drug Administration Amendments Act of 2007 S.1082 Prescription Drug User Fee Amendments of 2007 H.R.2716 Reducing Fraudulant and Imitation Drugs Act of 2007 S.251 Pharmaceutical Marketing Access Act of 2007 The Prescription Drug Marketing Act and various other bills and amendments relating to anti-counterfeiring/pedigree issues. Various other bills and amendments relating to prescription drug importation. S.1951 Fair Medicaid Drug Payment Act H.R.3140 Saving our Community Pharmacies Act H.R.3193 Access to Community Pharmacy Preservation Act

Client expense: $420,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, UNDETERMINED

HR 2716 and HR 4299 - To Extend the Terrorism Risk Insurance Act. S 618 and HR 1081 - To End the Insurance Industry's Antitrust Exemption under the McCarran-Ferguson Act. S. 40 and HR 3200 - To Establish an Optional Federal Charter for Insurance Companies. Supported bill to reduce regulatory/filing burden on surplus lines insurers.

Client expense: $140,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), SENATE, Treasury, Dept of

H.R. 2716 Reducing Fraudulant and Imitation Drugs Act of 2007 S. 251 Pharmaceutical Market Access Act of 2007 The Prescription Drug Marketing Act and various other bills and amendments relating to anti-counterfeiting/pedigree issues. Various other bills and amendments relating to prescription drug importation. H.R. 1902 Protecting Consumers Access to Generic Drugs Act of 2007 S. 316 Preserve Access to Affordable Generics Act H.R. 2900 Food and Drug Administration Amendments Act of 2007 S. 1082 Prescription Drug User Fee Amendments of 2007

Client expense: $560,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR2716 Reducing Fraudulent and Imitation Drugs Act of 2007; HR3192 Pregnant Women Support Act.

Client expense: $1,220,000 · Firm income: Not reported

Government targets: Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE

45. S.1932, the Deficit Reduction Act (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 46. S. 1548 - Department of Defense Authorization Act for Fiscal Year 2008 (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 47. H.R. 1585 - National Defense Authorization Act for Fiscal Year 2008 (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) 1. H.R. 4241, the Deficit Reduction Act of 2005 2. S. 1932, the Deficit Reduction Act of 2005 3. S. 1695, the Biologics Price Competition and Innovation Act of 2007 4. H.R.1038, Access to Life-Saving Medicine Act 5. S. 623, the Access to Life-Saving Medicine Act 6. H.R. 2900, the Food and Drug Administration Amendments of 2007 7. S. 1082, Food and Drug Administration Revitalization Act 8. H.R.1585, the National Defense Authorization Act 9. S. 1548 - Department of Defense Authorization Act for Fiscal Year 2008 10. S. 1693, the Wired for Health Care Quality Act of 2007 11. H.R. 1952, the National Health Information Incentive Act 12. H.R. 2747, the Methamphetamine Production Prevention Act of 2007 13. S. 1276, the Methamphetamine Production Prevention Act of 2007 14. H.R.1591, the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007 15. S. 3, the Medicare Fair Prescription Drug Price Act of 2007 16. S. 1088, the Lower Prices Reduced With Increased Competition and Efficient Development of Drugs Act 17. H.R. 1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007 18. S.242, the Pharmaceutical Market Access and Drug Safety Act of 2007 19. H.R. 800, the Employee Free Choice Act of 2007 20. S. 596, the Safe Internet Pharmacy Act of 2007 21. H.R.976, Small Business Tax Relief Act of 2007 22. H.R. 970, the Dextromethorphan Distribution Act of 2007 23. H.R. 971, the Community Pharmacy Fairness Act of 2007 24. S. 885, the Community Pharmacy Fairness Act of 2007 25. H.R. 2, the Fair Minimum Wage Act of 2007 26. S. 2, the Fair Minimum Wage Act of 2007 27. S. 484, the Enhancing Drug Safety and Innovation Act of 2007 28. H.R. 4, the Medicare Prescription Drug Price Negotiation Act of 2007 29. H.R.380, the Pharmaceutical Market Access and Drug Safety Act of 2007 30. H.R.3090, Patient and Pharmacy Protection Act of 2007 31. S.3, the Medicare Prescription Drug Price Negotiation Act of 2007 32. S.251, the Pharmaceutical Market Access Act of 2007 33. S. 604, the Military Health Care Protection Act 34. S. 980, Online Pharmacy Consumer Protection Act of 2007 35. S.1224, Children's Health Insurance Program (CHIP) Reauthorization Act of 2007 36. H.R.1845, the Medicare Durable Medical Equipment Access Act of 2007 37. H.R.1902, the Protecting Consumer Access to Generic Drugs Act of 2007 38. H.R. 2206, the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007 39. H.R. 2596, the Access to Birth Control Act 40. H.R.2716, the Reducing Fraudulent and Imitation Drugs Act of 2007 41. H.R.3043, the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008 42. S. 1710, the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2008 43. H.R.3161, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2008 44. H.R. 5182 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2006 (joint project with the National Community Pharmacists Association for Coalition for Community Pharmacy Action) See addendum

H.R. 5688 Healthcare Truth & Transparency Act; S.1515/H.R. 2716 Medicaid Advanced Practice Nurses & Physicians Act; H.R. 6188 Medicare Physician Assistant Continuity of Care Act

Client expense: Not reported · Firm income: Not reported

H.R. 5688 Healthcare Truth & Transparency Act; S.1515/H.R. 2716 Medicaid Advanced Practice Nurses & Physicians Act; H.R. 6188 Medicare Physician Assistant Continuity of Care Act

Client expense: Not reported · Firm income: Not reported